135 articles
Colin Lake, Vice President of Digital Business Transformation for Neurology at UCB, discusses the company’s approach to digital solutions and how they...
David Henley, MD, Executive Medical Director, Alzheimer’s Disease Global Medical Affairs, Neurology Business Group at Eisai Inc.
Maria Maccecchini, PhD, CEO of Annovis Bio discusses the company's lead program ANVS401 that has shown that it lowers levels of neurotoxic proteins f...
Rob Etherington, CEO at Clene Nanomedicine discusses the company's lead drug candidate CNM-Au8, a catalytically active gold nanotherapeutic that drives ...
Allitia DiBernardo, MD, Global Head of Medical Affairs-Neuroscience at Janssen discusses a presentation at the 2021 European Committee for Treatment and...
Hideki Garren, MD, PhD, Chief Medical Officer at Prothena discusses data from two presentations at the Alzheimer’s Association International Conferenc...
Over the past year, many people have missed or postponed medical appointments due to the pandemic. For people with chronic conditions like multiple sc...
Ed Fairburn, artist and one of the millions who has lived with migraine, discusses his unique art form using maps as portraits to show the complexities ...
Rachel Kuperman, MD, CEO and Founder of Eysz, a medtech/AI startup, discusses the company's AI-enabled Epilepsy Management Platform that they are buildi...
Hospice patients with dementia are up to four times more likely to be disenrolled before death than patients without dementia (PWD).